Your browser doesn't support javascript.
loading
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.
Flores-Montero, J; Sanoja-Flores, L; Paiva, B; Puig, N; García-Sánchez, O; Böttcher, S; van der Velden, V H J; Pérez-Morán, J-J; Vidriales, M-B; García-Sanz, R; Jimenez, C; González, M; Martínez-López, J; Corral-Mateos, A; Grigore, G-E; Fluxá, R; Pontes, R; Caetano, J; Sedek, L; Del Cañizo, M-C; Bladé, J; Lahuerta, J-J; Aguilar, C; Bárez, A; García-Mateo, A; Labrador, J; Leoz, P; Aguilera-Sanz, C; San-Miguel, J; Mateos, M-V; Durie, B; van Dongen, J J M; Orfao, A.
Affiliation
  • Flores-Montero J; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain (USAL).
  • Sanoja-Flores L; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain (USAL).
  • Paiva B; Clinica Universidad de Navarra; Applied Medical Research Center (CIMA), IDISNA, Pamplona, Spain (UNAV).
  • Puig N; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • García-Sánchez O; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Böttcher S; Second Department of Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany (UNIKIEL).
  • van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands (EMC).
  • Pérez-Morán JJ; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Vidriales MB; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • García-Sanz R; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Jimenez C; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • González M; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Martínez-López J; Department of Hematology, Hospital 12 de Octubre, Madrid, Spain.
  • Corral-Mateos A; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain (USAL).
  • Grigore GE; Cytognos SL, Salamanca, Spain.
  • Fluxá R; Cytognos SL, Salamanca, Spain.
  • Pontes R; Faculty of Medicine, Federal University of Rio de Janeiro and Institute of Pediatrics and Childhood Care, Rio de Janeiro, Brazil.
  • Caetano J; Department of Hematology, Portuguese Institute of Oncology, Lisbon, Portugal (IPOLFG).
  • Sedek L; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland (SUM).
  • Del Cañizo MC; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Bladé J; Department of Hematology, Hospital Clinic I Provincial, Barcelona, Spain.
  • Lahuerta JJ; Department of Hematology, Hospital 12 de Octubre, Madrid, Spain.
  • Aguilar C; Department of Hematology, Hospital General de Santa Bárbara, Soria, Spain.
  • Bárez A; Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain.
  • García-Mateo A; Department of Hematology, Complejo Asistencial de Segovia, Segovia, Spain.
  • Labrador J; Hematology Department, Hospital Universitario de Burgos, Burgos, Spain.
  • Leoz P; Cancer Research Center (IBMCC-CSIC/USAL-IBSAL); Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain (USAL).
  • Aguilera-Sanz C; Department of Hematology, Hospital El Bierzo, Ponferrada, Spain.
  • San-Miguel J; Clinica Universidad de Navarra; Applied Medical Research Center (CIMA), IDISNA, Pamplona, Spain (UNAV).
  • Mateos MV; Department of Hematology, University Hospital of Salamanca, IBSAL; IBMCC (USAL-CSIC), Salamanca, Spain (HUSAL).
  • Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA, USA.
  • van Dongen JJM; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands (EMC).
  • Orfao A; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
Leukemia ; 31(10): 2094-2103, 2017 10.
Article de En | MEDLINE | ID: mdl-28104919
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Plasmocytes / Immunophénotypage / Cytométrie en flux / Myélome multiple Type d'étude: Clinical_trials / Diagnostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2017 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Plasmocytes / Immunophénotypage / Cytométrie en flux / Myélome multiple Type d'étude: Clinical_trials / Diagnostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2017 Type de document: Article Pays de publication: Royaume-Uni